NCT00138086 Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00097929 An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013) Status COMPLETED Phase PHASE2
NCT00085696 VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00054665 PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00001582 Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer Status COMPLETED Phase N/A